Haemonetics acquires Vivasure Medical

Haemonetics agreed to acquire Vivasure Medical. Reported deal value: €100M. Status: Announced. Sector: medical technology. Target headquarters context: Galway, Connaught, Ireland.

This page summarizes publicly available information about the transaction as of 2026-01-13. Figures and status may change as filings and press coverage update.

Orchestra BioMed Holdings, Inc. , a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced that it expects to receive up to $ 21 million in cash proceeds in connection with the acquisition of Vivasure , an Ireland -based company pioneering next-generation technology for percutaneous vessel closure, by Haemonetics Corporation , which closed on January 9, 2026